Archive for January 2021
Biotech with Boston ties undergoes rebrand, strategic shift
"We are functionally a new company," the CEO says. Read More
Read MoreHaemonetics acquires California vascular company for up to $510M
Boston-based medical device company Haemonetics has an agreement to acquire a California-based vascular device company for up to $510 million. Read More
Read MorePE firm Fort Point Capital closes second fund at $194M
Former Fidelity Equity Partners executives Brooke Ablon and Paul Lipson co-founded the firm in 2010. Until now, Fort Point Capital has invested in two main areas: companies offering traditional business services and companies in the transportation and logistics sectors. Read More
Read MoreMilliporeSigma buys its Burlington HQ for $252M
Biomanufacturing equipment maker MilliporeSigma has bought its Burlington headquarters for a combined $252 million. Read More
Read MoreBiotech with Boston research hub has filed to go public. Here are the details.
The company will look to raise $100 million in its initial public offering. Read More
Read MoreBizSpotlight: Blue Moon Capital Partners LP
Second joint venture for the companies and largest Read More
Read MoreTwo PPP loans in the same round? Experts say it’s possible.
It might be tricky — and the timing tight — but here is how to get two PPP loans this round. Read More
Read MoreEditorial: Boston mayoral candidates should convene, not criticize
Boston Business Journal editorial: The city’s mayoral candidates should convene, not criticize, and should share their economic agenda. Read More
Read MoreUMass launches student volunteer ‘vaccine corps’
In partnership with the Baker administration, UMass is expanding its role in distributing Covid-19 vaccines. Read More
Read MoreBioMed buys Somerville site near Assembly for lab campus
The Somerville site can house 1.3 million square feet of development. Read More
Read More